Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
Eleven Biotherapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Eleven Biotherapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at Eleven Biotherapeutics received on average a compensation package of $2.7M, a 154% increase compared to previous year.
Average pay of disclosed executives at Eleven Biotherapeutics
Thomas R. Cannell, Chief Executive Officer, received $4.9M in total, which increased by 189% compared to 2020. 84% of Cannell's compensation, or $4.1M, was in option awards. Cannell also received $236K in non-equity incentive plan, $558K in salary, as well as $4K in other compensation.
Monica Forbes, Chief Financial Officer, received a compensation package of $1.9M, which increased by 135% compared to previous year. 64% of the compensation package, or $1.2M, was in option awards.
Glen MacDonald, Chief Technology Officer, earned $1.3M in 2021, a 89% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.